Macroview Investment Management LLC Biogen Inc. Transaction History

Macroview Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	BUY	$194.69 - $268.46 $9,734 - $13,422	50 New	50 $13,000
Q4 2019 Feb 05, 2020	SELL	$220.06 - $304.07 $3,961 - $5,473	-18 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$217.44 - $243.88 $217 - $243	1 Added 5.88%	18 $4,000
Q2 2019 Jul 23, 2019	BUY	$219.29 - $241.72 $3,727 - $4,109	17 New	17 $4,000
Q4 2018 Feb 07, 2019	SELL	$278.5 - $352.75 $3,342 - $4,233	-12 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$293.51 - $383.83 $3,522 - $4,605	12 New	12 $4,000

990

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Macroview Investment Management LLC with notifications on news.